Faculty & Staff at TUC

Kelan Thomas

Kelan Thomas

College: COP

Department: Clinical Sciences

Title: Associate Professor

Phone: (707) 638-5951

Fax: (707) 638-5959

E-Mail: kthomas10@touro.edu

Office: Administration & Faculty 2, Rm. 105


Master of Science, Clinical Research, University of Michigan, 2009

Doctor of Pharmacy, Pharmaceutical Sciences, University of California, San Francisco, 2007

Bachelor of Science, Chemistry with Pharmacology, Duke University, 2002 


Licenses and Certifications

California Registered Pharmacist, License #65548, 2011

Singapore Registered Pharmacist, License #02071J, 2010

Michigan Registered Pharmacist, License #5302038168, 2007

Certificate in Psychedelic-Assisted Therapies and Research, CIIS, 2018

Board Certified Psychiatric Pharmacist (BCPP), 2012

Board Certified Pharmacotherapy Specialist (BCPS), 2008

PGY-2 Psychiatric Pharmacy Residency, University of Southern California, 2012

PGY-1 Pharmacy Practice Residency, University of Michigan, 2008

Course Lecturer

PRMC 604: Clinical Sciences 1 

PRMC 610: Pharmaceutical Sciences 3  

PRMC 612: Clinical Sciences 3 (Course Coordinator) 

PRMC 621: Introductory Pharmacy Practice Experience 2

PRMC 623: Introductory Pharmacy Practice Experience 4 (Lab Presenter)

Clinical Practice 

PRMC 814: APPE Acute Care - Psychiatry (St. Helena Hospital Center for Behavioral Health) 


Research interests include psychopharmacology, medication-assisted psychotherapy, pharmacogenomics, connectomics and novel approaches to psychiatric therapy.  I hope to gain a better understanding of variations in psychotropic efficacy and safety with the goal of predicting optimal psychiatric treatment for individual patients.

Thomas KL, Muzyk AJ. Surveys of substance use disorders education in US pharmacy programs. Mental Health Clinician 2018;8(1):14–17.

Van Dyke P, Thomas KL. Concomitant calcium channel blocker and antipsychotic therapy in patients with schizophrenia: Efficacy analysis of the CATIE-Sz phase 1 data. Ann Clin Psychiatry. 2017;29(4):e1-e11.

Thomas KL
, Doroudgar, S. Lithium, In: Ray SD, Editor. Side Effects of Drugs Annual: A worldwide yearly survey of new data in adverse drug reactions, Vol. 39, pp. 23-30, Elsevier: Cambridge, 2017.

Dopheide JA, Bostwick JR, Goldstone LW, Thomas K, Nemire R, Gable KN, Cates M, Caballero J, Smith T, Bainbridge J. Curriculum in Psychiatry and Neurology for Pharmacy Programs. AJPE. 2017;81(7):Article 5925.

Muzyk AJ, Peedin E, Lipetzky J, Parker H, McEachern MP, Thomas K. Substance use education in US schools of pharmacy: A systematic review of the literature. Subst Abus. 2017;38(4):455–463.

Thomas K
, Malcolm B, Lastra D. Psilocybin-assisted therapy: a review of a novel treatment for psychiatric disorders. J Psychoactive Drugs. 2017;49(5):446-455.

Doroudgar S, Chuang HM, Perry PJ, Thomas K, Bohnert K, Canedo J. Driving performance comparing older versus younger drivers. Traffic Inj Prev. 2017;18(1):41-46.

Ray SD, Thomas KL, Kisor DF. ADRs, ADEs and SEDs: A Bird’s Eye View, In Side Effects of Drugs Annual: A worldwide yearly survey of new data in adverse drug reactions, Vol. 38, pp. xxvii-xli, Elsevier: Cambridge, 2016.

Maroney ME, Liu MT, Smith T, Thomas KL. Lithium, In: Ray SD, Editor. Side Effects of Drugs Annual: A worldwide yearly survey of new data in adverse drug reactions, Vol. 38, pp. 21-28, Elsevier: Cambridge, 2016.

Thomas K
, Canedo J, Perry PJ, et al. Effects of valerian on subjective sedation, field sobriety testing and driving simulator performance. Accid Anal Prev. 2016;92:240-244.

Thomas KL, La A, Punia S, Doroudgar S, Perry P.  Valproic acid-induced hyperammonemia and minimal hepatic encephalopathy prevalence among psychiatric inpatients. Annals of Clinical Psychiatry. 2016;28(1):37-42.

Nguyen L, Thomas KL, Lucke-wold BP, Cavendish JZ, Crowe MS, Matsumoto RR. Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders. Pharmacol Ther. 2016;159:1-22.

Perry PJ, Fredriksen K, Chew S, Ip EJ, Lopes I, Doroudgar S, Thomas K. The Effects of Dextromethorphan on Driving Performance and the Standardized Field Sobriety Test. J Forensic Sci. 2015;60(5):1258-62. 

Thomas KL
, Jiang Y, McCombs JS.  Clozapine revisited: Impact of clozapine vs olanzapine on health care use by schizophrenia patients on Medicaid. Ann Clin Psychiatry. 2015;27(2):90-9.

English BA, Thomas KL, Johnstone J, Bazih A, Gertsik L, Ereshefsky L.  Use of translational pharmacodynamic biomarkers in early-phase clinical studies for schizophrenia. Biomark Med. 2014;8(1):29-49. 

English BA, Thomas KL, Gertsik L, Ereshefsky L. Early phase drug development strategies to inform decision making and the viability of novel CNS compounds in schizophrenia. JCS. 2013;5(4):34-9.

English BA, Ereshefsky L, Thomas KL, Jhee S. Improving Transition of Investigational Medicines in Alzheimer’s Disease from Phase 1 to Phase 2. JCS. 2013;5(1):52-9.

Bly MJ, Bishop JR, Thomas KL, Ellingrod VL. P-glycoprotein (PGP) Polymorphisms and Sexual Dysfunction in Female Patients with Depression and SSRI-Associated Sexual Side Effects. J Sex Marital Ther. 2013;39(3):280-88.

Thomas KL, Ellingrod VL, Bishop JR, Keiser MJ. A Pilot Study of the Pharmacodynamic Impact of SSRI Drug Selection and Beta-1 Receptor Genotype (ADRB1) on Cardiac Vital Signs in Depressed Patients: A Novel Pharmacogenetic Approach. Psychopharmacol Bull. 2010;43(1):11-22.

Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, Hufeisen SJ, Jensen NH, Kuijer MB, Matos RC, Tran TB, Whaley R, Glennon RA, Hert J, Thomas KL, Edwards DD, Shoichet BK, Roth BL. Predicting new molecular targets for known drugs. Nature. 2009;462(7270):175-81.

Ellingrod VL, Bishop JR, Thomas KL. Pharmacogenomics of Psychiatry. In Pharmacogenomics: Applications to Patient Care, Second Edition. ACCP: Kansas City, 2009.

Thomas KL, Ellingrod VL. Pharmacogenetics of selective serotonin reuptake inhibitors and associated adverse drug reactions. Pharmacotherapy. 2009;29(7):822-31.

College of Psychiatric and Neurologic Pharmacists (CPNP)

American Society of Health-System Pharmacists (ASHP)

American Association of Colleges of Pharmacy (AACP)

WIRED Magazine Top 10 Scientific Breakthroughs of 2009



Associate Professor, Touro University California College of Pharmacy, 2013-Present

Drug Information Contributor, Lexicomp Inc., 2012-Present

Psychiatric Pharmacy Resident, LAC+USC Healthcare Network, 2011-2012

Psychiatric Pharmacist, Singapore Institute of Mental Health, 2009-2010

Pharmacy Practice Resident, University of Michigan Health System, 2007-2008


Last Updated: 3/15/22